Efficacy and safety of fremanezumab in patients with migraine and obesity: post-hoc analysis of the phase 3 HALO-LTS and FOCUS clinical trials

被引：0
|
作者：
Irimia Sieira, P. [1 ]
Torphy, B. [2 ]
Ortega, M. [3 ]
Barash, S. [3 ]
Krasenbaum, L. J. [3 ]
Akcicek, H. [4 ]
Smith, M. [2 ]
Ning, X. [3 ]
Campos, V. Ramirez [3 ]
机构：
[1] Clin Univ Navarra, Neurol Dept, Pamplona, Spain
[2] Chicago Headache Ctr & Res Inst, Chicago, IL USA
[3] Teva Branded Pharmaceut Prod R&D Inc, W Chester, PA USA
[4] Teva Netherlands BV, Amsterdam, Netherlands
来源：
JOURNAL OF HEADACHE AND PAIN | 2024年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P035
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Efficacy and safety of dronedarone after recent cardioversion in patients with atrial fibrillation/flutter: a post-hoc analysis of the EURIDIS/ADONIS trials
    Thind, M.
    Crijns, H. J.
    Naccarelli, G. V.
    Reiffel, J. A.
    Genti, V. Corp Dit
    Wieloch, M.
    Koren, A.
    Kowey, P. R.
    EUROPEAN HEART JOURNAL, 2019, 40 : 1193 - 1193
  • [32] Efficacy and safety of sarilumab in patients with rheumatoid arthritis stratified by age (<65 and ≥65 years): A post hoc analysis of Japanese Phase 3 clinical trials
    Tanaka, Yoshiya
    Takahashi, Toshiya
    van Hoogstraten, Hubert
    Kato, Naoto
    Kameda, Hideto
    MODERN RHEUMATOLOGY, 2024, 35 (01) : 34 - 41
  • [33] EFFICACY OF TOFACITINIB BY BACKGROUND METHOTREXATE DOSE IN PATIENTS WITH PSORIATIC ARTHRITIS: A POST-HOC ANALYSIS OF POOLED DATA FROM 2 PHASE 3 TRIALS
    Kivitz, A. J.
    FitzGerald, O.
    Nash, P.
    Pang, S.
    Azevedo, V. F.
    Kudlacz, E.
    Wang, C.
    Graham, D.
    Takiya, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1575 - 1575
  • [34] BARICITINIB EFFICACY IN MODERATE RHEUMATOID ARTHRITIS - A POST-HOC ANALYSIS FROM TWO PHASE III TRIALS
    Kirkham, Bruce W.
    Nikiphorou, Elena
    Edwards, Christopher J.
    Sheesh, Mohamed
    Haladyj, Ewa
    Gerwien, Jens
    Zaremba-Pechmann, Liliana
    Taylor, Peter C.
    RHEUMATOLOGY, 2023, 62
  • [35] Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in adults with haematological malignancies: a phase 3, randomised, clinical trial and post-hoc efficacy analysis
    Dagnew, Alemnew F.
    Ilhan, Osman
    Lee, Won-Sik
    Woszczyk, Dariusz
    Kwak, Jae-Yong
    Bowcock, Stella
    Sohn, Sang Kyun
    Rodriguez Macias, Gabriela
    Chiou, Tzeon-Jye
    Quiel, Dimas
    Aoun, Mickael
    Navarro Matilla, Maria Belen
    de la Serna, Javier
    Milliken, Samuel
    Murphy, John
    McNeil, Shelly A.
    Salaun, Bruno
    Di Paolo, Emmanuel
    Campora, Laura
    Lopez-Fauqued, Marta
    El Idrissi, Mohamed
    Schuind, Anne
    Heineman, Thomas C.
    Van den Steen, Peter
    Oostvogels, Lidia
    LANCET INFECTIOUS DISEASES, 2019, 19 (09): : 988 - 1000
  • [36] Safety and Tolerability of Fremanezumab in Patients With Episodic and Chronic Migraine: a Pooled Analysis of Phase 3 Studies
    Vargas, Bert B.
    Ning, Xiaoping
    Kessler, Yoel
    Cohen, Joshua M.
    Campos, Verena Ramirez
    Yang, Ronghua
    McAllister, Peter
    NEUROLOGY, 2020, 94 (15)
  • [37] Cardiovascular Safety of Fremanezumab in Patients with Episodic and Chronic Migraine: A Pooled Analysis of Phase 3 Studies
    Nahas, Stephanie J.
    Kessler, Yoel
    Ning, Xiaoping
    Cohen, Joshua M.
    Campos, Verena Ramirez
    Yang, Ronghua
    Silberstein, Stephen D.
    NEUROLOGY, 2020, 94 (15)
  • [38] Safety and tolerability of fremanezumab in patients with episodic and chronic migraine: a pooled analysis of phase 3 studies
    Diener, Hans Christoph
    McAllister, Peter
    Jurgens, Tim P.
    Kessler, Yoel
    Ning, Xiaoping
    Cohen, Joshua M.
    Campos, Verena Ramirez
    Barash, Steve
    Silberstein, Stephen D.
    CEPHALALGIA, 2022, 42 (08) : 769 - 780
  • [39] Safety and Tolerability of Fremanezumab in Patients with Episodic and Chronic Migraine: A Pooled Analysis of Phase 3 Studies
    McAllister, Peter
    Ning, Xiaoping
    Kessler, Yoel
    Cohen, Joshua M.
    Campos, Verena Ramirez
    Yang, Ronghua
    ANNALS OF NEUROLOGY, 2020, 88 : S158 - S159
  • [40] Efficacy and Safety of Eslicarbazepine Acetate According to Epilepsy Etiology: A Post-hoc Analysis of Three Phase III Trials in Adults with Focal Seizures
    Cantu, David
    Grinnell, Todd
    Magalhaes, Luis
    Loureiro, Rui
    Tosiello, Robert
    Blum, David
    NEUROLOGY, 2020, 94 (15)
12345